NeuroPace Inc (NPCE): Net Income

Annual figures by period end, from SEC filings.

-$21.46M

Year ended 2025-12-31

-$19.11M

Trailing 12 months to 2026-06-30

2020-12-31 Net Income (USD) 2025-12-31

Period ended	Net Income	Change YoY	Source filing
2025-12-31	-$21.46M	n/m	2026-03-03, From 2025-01-01
2024-12-31	-$27.14M	n/m	2026-03-03, From 2024-01-01
2023-12-31	-$32.96M	n/m	2025-03-04, From 2023-01-01
2022-12-31	-$47.08M	n/m	2024-03-05, From 2022-01-01
2021-12-31	-$36.08M	n/m	2023-03-02, From 2021-01-01
2020-12-31	-$24.28M	n/a	2022-03-10, From 2020-01-01

Net Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
NeuroPace Inc (NPCE)	2025-12-31	-$21.46M	n/m
Beta Bionics, Inc. (BBNX)	2025-12-31	-$73.20M	n/m
Kestra Medical Technologies, Ltd. (KMTS)	2026-04-30	-$131.61M	n/m
Pulmonx Corp (LUNG)	2025-12-31	-$54.00M	n/m
Anika Therapeutics, Inc. (ANIK)	2025-12-31	-$10.88M	n/m
Orasure Technologies Inc (OSUR)	2025-12-31	-$68.73M	n/m
Delcath Systems, Inc. (DCTH)	2025-12-31	$2.70M	n/m
Iradimed Corp (IRMD)	2025-12-31	$22.48M	+16.9%
TELA Bio, Inc. (TELA)	2025-12-31	-$38.83M	n/m

Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗